BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18641021)

  • 1. Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies.
    Fernández A; De Arriba F; Rivera J; Heras I; Vicente V; Lozano ML
    Haematologica; 2008 Sep; 93(9):1436-8. PubMed ID: 18641021
    [No Abstract]   [Full Text] [Related]  

  • 2. G-CSF-stimulated BM progenitor cells supplement suboptimal peripheral blood hematopoietic progenitor cell collections for auto transplantation.
    Seshadri T; Al-Farsi K; Stakiw J; Ma C; Saragosa R; Franke N; Keating A; Crump M; Kuruvilla J
    Bone Marrow Transplant; 2008 Dec; 42(11):733-7. PubMed ID: 18711349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective analysis of adverse events based on a dose and a schedule in patients who underwent paclitaxel- containing chemotherapy].
    Yoshimura T; Hirade K; Iihara H; Ishihara M; Komori Y; Okayasu S; Matsuura K; Yasuda T; Itoh Y
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1721-6. PubMed ID: 18931576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic chemotherapy using paclitaxel and carboplatin plus regional hyperthermia and hyperbaric oxygen treatment for non-small cell lung cancer with multiple pulmonary metastases: preliminary results.
    Ohguri T; Imada H; Narisada H; Yahara K; Morioka T; Nakano K; Miyaguni Y; Korogi Y
    Int J Hyperthermia; 2009 Mar; 25(2):160-7. PubMed ID: 19337916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer].
    Usui N
    Gan To Kagaku Ryoho; 2010 May; 37(5):805. PubMed ID: 20524247
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical values of biomarkers in hematopoietic malignancies].
    Kawaguchi T; Nosaka K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):26-31. PubMed ID: 19151562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
    Lee SJ; Cho SH; Yoon JY; Hwang JE; Bae WK; Shim HJ; Chung IJ
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):159-66. PubMed ID: 19479256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegfilgrastim successfully mobilizes megakaryocyte progenitors into the peripheral blood in subjects with solid tumours.
    Willis F; Theti D; Dean S; Bacon P; Baker N; Pettengell R
    Bone Marrow Transplant; 2008 Aug; 42(3):167-73. PubMed ID: 18500375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting hematopoietic progenitor cell mobilization: an analysis of 307 patients.
    Mendrone A; Arrais CA; Saboya R; Chamone Dde A; Dulley FL
    Transfus Apher Sci; 2008 Dec; 39(3):187-92. PubMed ID: 19036640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chemotherapy on plasma lipids and lipoproteins in Nigerian patients with haematological malignancy.
    Idogun SE; Omoti CE
    Niger Postgrad Med J; 2011 Mar; 18(1):16-9. PubMed ID: 21445108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transfusion in haematology].
    Renaudier P
    Transfus Clin Biol; 2008 Nov; 15(5):228-35. PubMed ID: 18930422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
    Sobecks RM; Dean R; Rybicki LA; Chan J; Theil KS; Macklis R; Andresen S; Kalaycio M; Pohlman B; Ferraro C; Cherni K; Sweetenham J; Copelan E; Bolwell BJ
    Bone Marrow Transplant; 2008 Dec; 42(11):715-22. PubMed ID: 18711346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
    Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
    Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
    Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG
    Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of telomerase and its clinical application in blood cells].
    Yamada O
    Rinsho Ketsueki; 2007 Feb; 48(2):117-33. PubMed ID: 17370640
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.